QT Imaging (NASDAQ:QTI) Releases Earnings Results, Beats Estimates By $0.03 EPS

QT Imaging (NASDAQ:QTI) announced its earnings results on Wednesday. The company reported ($0.19) EPS for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.03, Zacks reports. The business had revenue of $7.60 million for the quarter, compared to analysts’ expectations of $7.60 million. QT Imaging had a negative net margin of 58.93% and a negative return on equity of 4,220.38%.

Here are the key takeaways from QT Imaging’s conference call:

• Second-quarter revenue more than doubled year over year to $7.4 million, driven by 15 scanner shipments versus eight in the prior-year period. First-half revenue reached $14 million on 28 shipments, and management reaffirmed approximately $39 million in 2026 revenue guidance.
• QT Imaging expanded its commercial and international infrastructure, adding U.S. regional sales leadership and securing regulatory authorization in Saudi Arabia and Israel. The company expects to ship another 15 scanners in the third quarter and 17 in the fourth quarter, primarily through NXC Imaging.
• The company highlighted clinical and reimbursement progress, including a dedicated Category III CPT code effective January 1, 2027, a study at Mayo Clinic involving more than 100 patients, and evidence showing less than 1% variability in speed-of-sound measurements across scanners.
• Gross margin declined to 41% from 50% a year earlier, while operating expenses increased to $4.9 million. The net loss widened to $11.1 million, including an $8.3 million non-cash loss tied to the company’s debt amendment; the amended loan also carries a higher interest rate of 12% versus 10%.
• Management acknowledged that scanner deployment and customer utilization are progressing more slowly than desired, requiring the company to spend the next several months helping NXC Imaging place scanners with customers. Second-half operating expenses are expected to rise modestly due to sales hiring and clinical-study costs.

QT Imaging Stock Up 4.2%

Shares of QT Imaging stock opened at $3.01 on Thursday. QT Imaging has a one year low of $1.82 and a one year high of $8.50. The company has a market cap of $41.45 million, a P/E ratio of -2.43 and a beta of -0.01. The company has a debt-to-equity ratio of 1.38, a quick ratio of 1.69 and a current ratio of 2.49. The firm has a fifty day moving average of $3.46 and a two-hundred day moving average of $5.15.

Analyst Ratings Changes

QTI has been the topic of a number of recent research reports. Weiss Ratings restated a “sell (e+)” rating on shares of QT Imaging in a research note on Friday, July 10th. Zacks Research upgraded shares of QT Imaging from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. Finally, Wall Street Zen raised QT Imaging to a “hold” rating in a report on Saturday, May 16th. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold”.

QT Imaging Company Profile

QT Imaging Ltd. (NASDAQ: QTI) is a medical technology company specializing in the development and commercialization of advanced ultrasound imaging solutions. The company focuses on real-time volumetric imaging systems designed to enhance diagnostic capabilities in obstetrics, gynecology and other clinical applications. QT Imaging’s flagship Q.VIEW® system and associated software suite enable practitioners to capture, analyze and visualize high-resolution 3D/4D ultrasound images, offering improved workflow efficiency and enhanced patient care.

QT Imaging’s product portfolio includes proprietary transducers, imaging consoles and software platforms that can be integrated with existing ultrasound scanners from leading original equipment manufacturers.